Catherine Pachuk
2021
In 2021, Catherine Pachuk earned a total compensation of $298.8K as Chief Scientific Officer and Executive Vice President at MARIZYME, a 31% increase compared to previous year.
Compensation breakdown
| Salary | $298,750 |
|---|---|
| Total | $298,750 |
Pachuk received $298.8K in salary, accounting for 100% of the total pay in 2021.
Rankings
In 2021, Catherine Pachuk's compensation ranked 11,625th out of 12,415 executives tracked by ExecPay. In other words, Pachuk earned more than 6.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,625 out of 12,415 | 6th |
Division Manufacturing | 5,117 out of 5,501 | 7th |
Major group Chemicals And Allied Products | 2,256 out of 2,371 | 5th |
Industry group Drugs | 2,001 out of 2,092 | 4th |
Industry Pharmaceutical Preparations | 1,477 out of 1,542 | 4th |
Source: SEC filing on November 10, 2022.
Pachuk's colleagues
We found seven more compensation records of executives who worked with Catherine Pachuk at MARIZYME in 2021.
2021
Steven Brooks
MARIZYME
Chief Medical Officer
2021
Amy Chandler
MARIZYME
Former Executive Vice President of Regulatory Affairs and Quality Management Systems
2021
James Sapirstein
MARIZYME
Chief Executive Officer
2021
Neil Campbell
MARIZYME
Chief Executive Officer
2021
Roger Schaller
MARIZYME
former Executive Vice President of Commercial Operations
2021
David Barthel
MARIZYME
Chief Executive Officer
2021
Vithalbhai Dhaduk
MARIZYME